Report Categories
View AllRecent Articles
View All
AbbVie Inc ABBV Submits SKYRIZI Subcutaneous Crohns Regimen to FDA But NearTerm Upside Remains Capped By Competitive Risks
OXSQH Oxford releases quarterly earnings report with key performance metrics still unavailable to public investors
MAIN Main notches slight share gain after Q4 2025 earnings top consensus EPS estimates by 43 percent
KTWOU K2 Capital outlines targeted tech sector acquisition plans in its latest quarterly earnings update